Janux Therapeutics (JANX) Return on Sales [ROS] (2021 - 2026)
Janux Therapeutics (JANX) recorded Return on Sales [ROS] of -308.66% in Q2 2026, up 32693.39 percentage points from -33002.05% a year earlier and up 607.84 percentage points from the prior quarter.
Janux Therapeutics (JANX) Return on Sales [ROS] (2021 - 2026) Analysis & Trends
On a TTM basis, Janux Therapeutics' Return on Sales [ROS] came in at -598.15% as of Jun 30, 2026, up 32403.90 percentage points year-over-year; for FY2025, it came in at -1576.67%, down 643.09 percentage points from FY2024.
- Annual Return on Sales [ROS] has declined for three straight years, with a four-year change of -671.28 percentage points (FY2021 to FY2025).
- Across earlier years, Return on Sales [ROS] came in at -933.58% in FY2024 (-30.71 pp), -902.87% in FY2023 (-123.83 pp), -779.04% in FY2022 (+126.35 pp) and -905.39% in FY2021.
- The Q2 2026 figure is the highest quarterly Return on Sales [ROS] since Q2 2024.
- On a year-over-year basis, Return on Sales [ROS] rose in four of the last eight quarters, with an average year-over-year change of -13.09 percentage points.
- Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 32693.39 percentage points in Q2 2026, against a drop of 32846.69 percentage points in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at -916.50% (Q1 2026), -1576.67% (Q4 2025) and -352.51% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Janux Therapeutics | 1.03 Bn | 1.03 Bn | - | -308.66% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -308.66% |
| Mar 31, 2026 | -916.50% |
| Dec 31, 2025 | -1,576.67% |
| Sep 30, 2025 | -352.51% |
| Jun 30, 2025 | -33,002.05% |
| Mar 31, 2025 | -1,216.61% |
| Dec 31, 2024 | -933.58% |
| Sep 30, 2024 | -8,164.46% |
| Jun 30, 2024 | -155.36% |
| Mar 31, 2024 | -1,610.30% |
| Dec 31, 2023 | -655.71% |
| Sep 30, 2023 | -628.25% |
| Jun 30, 2023 | -1,962.91% |
| Mar 31, 2023 | -990.28% |
| Dec 31, 2022 | -642.04% |
| Sep 30, 2022 | -994.04% |
| Jun 30, 2022 | -729.85% |
| Mar 31, 2022 | -852.23% |
| Dec 31, 2021 | -834.78% |
| Sep 30, 2021 | -940.72% |
Janux Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=JANX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "JANX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=JANX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();